摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

but-2-ynyl-isopropyl ether | 77180-23-5

中文名称
——
中文别名
——
英文名称
but-2-ynyl-isopropyl ether
英文别名
1-Isopropyloxy-butin-(2);But-2-inyl-isopropyl-aether;1-Propan-2-yloxybut-2-yne
but-2-ynyl-isopropyl ether化学式
CAS
77180-23-5
化学式
C7H12O
mdl
——
分子量
112.172
InChiKey
QOBVYLVFSZIMEK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    8
  • 可旋转键数:
    2
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

点击查看最新优质反应信息

文献信息

  • Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
    申请人:Saksena K. Anil
    公开号:US20070032433A1
    公开(公告)日:2007-02-08
    The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
    本发明揭示了具有HCV蛋白酶抑制活性的新化合物,以及制备这些化合物的方法。在另一种实施方式中,本发明揭示了包含这些化合物的药物组合物,以及使用它们治疗与HCV蛋白酶相关的疾病的方法。
  • Inhibitors of human immunodeficiency virus replication
    申请人:TSANTRIZOS Youla S.
    公开号:US20080221159A1
    公开(公告)日:2008-09-11
    Compounds of formula I: wherein a, b, c, X, R 2 , R 3 , R 4 , R 6 and R 7 are defined herein, are useful as inhibitors of HIV replication.
    式I的化合物:其中a、b、c、X、R2、R3、R4、R6和R7如此定义,对于抑制HIV复制是有用的。
  • NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS
    申请人:Saksena Anil K.
    公开号:US20110117057A1
    公开(公告)日:2011-05-19
    The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
    本发明披露了具有HCV蛋白酶抑制活性的新化合物,以及制备这些化合物的方法。在另一种实施方式中,本发明披露了包含这些化合物的制药组合物,以及使用它们治疗与HCV蛋白酶相关的疾病的方法。
  • The Effect on Attribute Prediction of Location Uncertainty in Spatial Data
    作者:John Gabrosek、Noel Cressie
    DOI:10.1111/j.1538-4632.2002.tb01088.x
    日期:2002.7
    A datum is considered spatial if it contains location information. Typically, there is also attribute information, whose distribution depends on its location. Thus, error in location information can lead to error in attribute information, which is reflected ultimately in the inference drawn from the data. We propose a statistical model for incorporating location error into spatial data analysis. We investigate the effect of location error on the spatial lag, the covariance function, and optimal spatial linear prediction (that is, kriging). We show that the form of kriging after adjusting for location error is the same as that of kriging without adjusting for location error. However, location error changes entries in the matrix of explanatory variables, the matrix of co‐variances between the sample sites, and the vector of covariances between the sample sites and the prediction location. We investigate, through simulation, the effect that varying trend, measurement error, location error, range of spatial dependence, sample size, and prediction location have on kriging after and without adjusting for location error. When the location error is large, kriging after adjusting for location error performs markedly better than kriging without adjusting for location error, in terms of both the prediction bias and the mean squared prediction error.
  • Alcohol addition products of unsaturated compounds and process for producing same
    申请人:DU PONT
    公开号:US02013725A1
    公开(公告)日:1935-09-10
查看更多